SCHEMBL4741735

SCHEMBL4741735

CN(C)CCCn1cnc2ccc(C(F)(F)F)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRPS1 P60891 1/20 0.52
TP53 P04637 2/20 0.44
NPC1 O15118 1/20 0.44
ABCB11 O95342 1/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
ABCB1 P08183 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2D6 P10635 1/20 0.44
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.44
DRD1 P21728 1/20 0.44
TBXA2R P21731 1/20 0.44
SLC6A2 P23975 1/20 0.44
MAPK1 P28482 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21025786 0.88 TGFBR1 (0.43) PRPS1TP53TSHRKCNH2LMNA
SCHEMBL19848146 0.85 LMNA (0.56) PRPS1TP53TSHRLMNAMAPT
SCHEMBL19848506 0.82 PRPS1 (0.51) PRPS1NPC1RAB9ALMNANPSR1
SCHEMBL18731437 0.81 LMNA (0.47) TP53LMNAMAPTMEN1KMT2A
SCHEMBL11347338 0.80 PRPS1 (0.48) PRPS1NPC1HTR1ATBXA2RRAB9A
SCHEMBL18731877 0.80 EGFR (0.48) TP53NPC1RAB9ALMNAMAPT
SCHEMBL21025781 0.80 HTR6 (0.42) PRPS1CYP1A2KCNH2LMNAMAPT
SCHEMBL19915934 0.79 PRPS1 (0.45) PRPS1LMNAQPCTCNR2
SCHEMBL21026260 0.77 MAPT (0.48) TP53KCNH2LMNAMAPTTDP1
SCHEMBL10025500 0.77 FGFR1 (0.54) TP53NPC1CYP1A2CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008084218-A1 BENZAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-17 WO disclosed